RABNEXT-A

Treat Pain. Protect the Stomach.

10x10 Protected Relief Capsules

Pharma

Pain Relief

Product highlights

Dual-action combination for pain relief with gastric protection
Provides sustained anti-inflammatory action with reduced GI risk
Ideal for long-term NSAID therapy
Improves mobility and reduces pain, swelling & stiffness
Promotes ulcer healing and better gastric safety

RABNEXT-A is a smart dual-action combination of Rabeprazole 20mg and Aceclofenac SR 200mg designed for effective pain management with gastrointestinal protection. It is suitable for arthritis, musculoskeletal pain, and patients requiring long-term NSAID therapy with reduced gastric complications.

Dosage Form

Sustained Release Capsules

Product Name

RABNEXT-A

Composition

Rabeprazole 20mg + Aceclofenac 200mg (Sustained Release)

Therapeutic Segment

Pain Management / Anti-inflammatory / Gastroprotective Therapy

Pharmacological Action

Aceclofenac provides anti-inflammatory and analgesic action while Rabeprazole suppresses gastric acid secretion for GI protection.

Mechanism

Aceclofenac inhibits cyclooxygenase enzymes reducing inflammation and pain, while Rabeprazole inhibits proton pump activity to decrease gastric acid secretion and protect the stomach lining.

Key Clinical Benefits

Effective long-lasting pain relief
Reduced gastric irritation and ulcer risk
Improves mobility and reduces stiffness
Promotes gastric healing and comfort
Suitable for chronic inflammatory conditions

Key Indications

Osteoarthritis
Rheumatoid Arthritis
Musculoskeletal pain
Post-operative and dental pain
Patients at GI risk requiring NSAIDs

Administration

To be taken orally after meals or as directed by the physician.

Recommended Usage

One capsule once daily or as prescribed by the physician.

Dosage Form

Sustained Release Capsules

Product Name

RABNEXT-A

Composition

Rabeprazole 20mg + Aceclofenac 200mg (Sustained Release)

Therapeutic Segment

Pain Management / Anti-inflammatory / Gastroprotective Therapy

Pharmacological Action

Pain Management / Anti-inflammatory / Gastroprotective Therapy

Mechanism

Aceclofenac inhibits cyclooxygenase enzymes reducing inflammation and pain, while Rabeprazole inhibits proton pump activity to decrease gastric acid secretion and protect the stomach lining.

Key Clinical Benefits